Concepedia

Author

Carol Babij

Amgen (United States)

Also Known As

Carol Babij, Carol M Babij

29

Publications

1.4K

Citations

7

H-Index

38

Concepts

All Affiliations

Amgen (United States)University College London
CB

About

Carol Babij is an author at Amgen (United States) specializing in medicine, cell biology, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

1.4K

2

Cell Biology

5

5

1.3K

3

Natural Sciences

2

2

117

4

Cellular Physiology

2

2

1.1K

5

Biochemistry

1

1

103

Carol Babij

×

7

Publications

1.4K

Citations

7

H-Index

YearCitations

A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death

Jonathan Ham, Carol Babij, Jonathan R. Whitfield,

Neuron

1995

796

Role of the Jun Kinase Pathway in the Regulation of c-Jun Expression and Apoptosis in Sympathetic Neurons

Andreas Eilers, Jonathan R. Whitfield, Carol Babij,

Journal of Neuroscience

1998

287

STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells

Carol Babij, Yihong Zhang, Robert J. Kurzeja,

Cancer Research

2011

126

Selective Inhibitors of the Mutant B-Raf Pathway: Discovery of a Potent and Orally Bioavailable Aminoisoquinoline

Adrian L. Smith, Frenel DeMorin, Nick A. Paras,

Journal of Medicinal Chemistry

2009

103

Selective and Potent Raf Inhibitors Paradoxically Stimulate Normal Cell Proliferation and Tumor Growth

Josette Carnahan, Pedro J. Beltran, Carol Babij,

Molecular Cancer Therapeutics

2010

75

Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression

Eric M. Parker, Angela Monopoli, Ennio Ongini,

Neuropharmacology

2000

41

Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling

Longbin Liu, Matthew R. Lee, Joseph L. Kim,

Bioorganic & Medicinal Chemistry

2016

14

Page 1